×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Still Space for Multiple Neulasta Biosimilars, says Pfenex
BioProcess International
Pfenex has deprioritized its pegfilgrastim biosimilar program but is reevaluating the market after Mylan's recent success in the US.
3 months ago
Ligand Buys Pfenex in $516 Million Deal to Access Protein Production Platform
BioSpace
San Diego-based Ligand Pharmaceuticals is acquiring San Diego-based Pfenex for a total deal transaction of up to $516 million. Pfenex'...
45 months ago
Earnings Preview: Pfenex (PFNX) Q2 Earnings Expected to Decline
Yahoo Movies UK
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key...
3 weeks ago
Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand,” the “Company” or “we”) announced that it has...
8 months ago
Ligand Pharmaceuticals agrees to acquire Pfenex for $516m
Pharmaceutical Technology
Ligand Pharmaceuticals has agreed to acquire development and licencing biotechnology firm Pfenex in a deal valued at approximately $516m.
45 months ago
Ligand Pharmaceuticals to acquire fellow San Diego biotech Pfenex for up to $516M
San Diego Union-Tribune
Ligand Pharmaceuticals is set to acquire Pfenex in the fourth quarter of 2020. The two San Diego biotechs rely on developing early-stage...
45 months ago
Wilson Sonsini Represents Pfenex in Acquisition by Ligand
Wilson Sonsini
On August 10, 2020, Ligand Pharmaceuticals and Pfenex Inc. announced the signing of a definitive agreement for Ligand to acquire all...
45 months ago
Pfenex to Regain Full Rights to PF582 and Announces Phase 1/2 Results
PR Newswire
Pfenex Inc. is a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value and difficult to...
93 months ago
Ligand to Acquire Pfenex Inc.
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Pfenex Inc. (NYSE American: PFNX) today announced the signing...
45 months ago
Pfenex Anthrax Vaccine Shows Good Early Results
Global Biodefense
Pfenex Inc. this week announced positive immunogenicity and safety data from the Day 70 analysis of the Px563L anthrax vaccine study.
93 months ago